Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2405923 | Vaccine | 2009 | 5 Pages |
Abstract
Determining incidence rates of potential adverse events before and after an immunisation programme is initiated, provides a useful framework for the evaluation of vaccine safety concerns. Human papillomavirus vaccination (HPV) of adolescent girls has recently been introduced in Denmark. Using a nationwide hospitalisation registry we estimated incidence rates of immune-mediated disorders before HPV vaccination in a cohort of 418,289 Danish girls aged 12-15 years. We further estimated the expected number of cases of immune-mediated disorders occurring in temporal relationship to a hypothetical HPV vaccination schedule purely by chance. Our results and analytical approach provides a framework for the evaluation of adverse event reports following immunisation of adolescent girls.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Torbjörn Callréus, Henrik Svanström, Nete Munk Nielsen, Sigrid Poulsen, Palle Valentiner-Branth, Anders Hviid,